IDEAYA BIOSCIENCES INC's ticker is IDYA and the CUSIP is 45166A102. A total of 144 filers reported holding IDEAYA BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,871,318 | -17.5% | 2,144,971 | -28.2% | 2.33% | -4.9% |
| Q2 2023 | $70,163,950 | +39.1% | 2,985,700 | -18.7% | 2.45% | +46.4% |
| Q1 2023 | $50,435,782 | -27.4% | 3,673,400 | -4.0% | 1.67% | +11.2% |
| Q4 2022 | $69,496,616 | +25.4% | 3,824,800 | +2.9% | 1.51% | +33.6% |
| Q3 2022 | $55,434,000 | +35.1% | 3,715,400 | +25.0% | 1.13% | +19.6% |
| Q2 2022 | $41,027,000 | +36.3% | 2,972,947 | +10.5% | 0.94% | +50.2% |
| Q1 2022 | $30,101,000 | -50.1% | 2,690,000 | +5.4% | 0.63% | -51.0% |
| Q4 2021 | $60,353,000 | -2.8% | 2,553,000 | +4.8% | 1.28% | -7.0% |
| Q3 2021 | $62,119,000 | +43.0% | 2,437,000 | +17.7% | 1.38% | +17.2% |
| Q2 2021 | $43,449,000 | +25.6% | 2,070,000 | +40.6% | 1.17% | +22.8% |
| Q1 2021 | $34,592,000 | +162.1% | 1,472,000 | +40.1% | 0.96% | +56.2% |
| Q3 2020 | $13,198,000 | -30.2% | 1,050,800 | -21.1% | 0.61% | -49.5% |
| Q2 2020 | $18,915,000 | – | 1,331,100 | – | 1.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners X LLC | 2,660,713 | $29,774,000 | 30.23% |
| Logos Global Management LP | 2,850,000 | $31,892,000 | 4.14% |
| 5AM Venture Management, LLC | 1,398,066 | $15,644,000 | 3.42% |
| ACT CAPITAL MANAGEMENT, LLC | 173,500 | $1,941,000 | 2.05% |
| DAFNA Capital Management LLC | 490,061 | $5,484,000 | 1.43% |
| Boxer Capital, LLC | 2,202,812 | $24,649,000 | 1.27% |
| BVF INC/IL | 1,600,559 | $17,910,000 | 0.72% |
| Avidity Partners Management LP | 2,690,000 | $30,101,000 | 0.63% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 62,929 | $704,000 | 0.43% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 109,000 | $1,623,000 | 0.37% |